文献速递呼吸衰竭与机械通气儿科与产科急症重症综合管理与镇静镇痛

儿童呼吸衰竭后功能衰退与生活质量受损的危险因素

Risk Factors for Functional Decline and Impaired Quality of Life after Pediatric Respiratory Failure.
PubMed 文献 · Am J Respir Crit Care Med · 2019-01-01
一句话结论儿童急性呼吸衰竭机械通气后约五分之一出院后功能衰退,约两成HRQL受损;功能衰退与基线功能受损、早产、癌症、呼吸衰竭病因、通气时长及可乐定相关(OR=2.14)。

本研究基于RESTORE试验(儿童急性呼吸衰竭机械通气镇静滴定随机评估),纳入2周至17岁患儿,评估基线、出院时及儿科ICU出院后6个月的功能状态和出院后6个月的健康相关生活质量(HRQL)。949例中192例(约五分之一)从基线至出院后功能衰退;271例中55例(20%)生长与发育受损;343例中64例(19%)HRQL受损。多变量分析显示功能衰退与基线功能受损、早产、癌症、呼吸衰竭病因、通气时长及可乐定相关(OR=2.14,95%CI 1.22-3.76);生长与发育受损的独立预测因素包括美沙酮(OR=2.27,95%CI 1.18-4.36)和疼痛管理不足(OR=2.94,95%CI 1.39-6.19);HRQL受损与年龄较大、非白人/西班牙裔、癌症及镇静管理不足相关(OR=3.15,95%CI 1.74-5.72)。结论认为儿童呼吸衰竭后出院后发病率常见,与入院因素、重症治疗暴露及疼痛和镇静管理相关。

要点

  • 949例机械通气急性呼吸衰竭患儿中192例(约五分之一)从基线至出院后功能衰退。
  • 271例中55例(20%)生长与发育受损;343例中64例(19%)健康相关生活质量(HRQL)受损。
  • 功能衰退与基线功能受损、早产、癌症、呼吸衰竭病因、通气时长及可乐定相关(OR=2.14,95%CI 1.22-3.76)。
  • 生长与发育受损的独立预测因素包括美沙酮(OR=2.27,95%CI 1.18-4.36)和疼痛管理不足(OR=2.94,95%CI 1.39-6.19)。
  • HRQL受损与年龄较大、非白人/西班牙裔、癌症及镇静管理不足相关(OR=3.15,95%CI 1.74-5.72)。

适用人群与场景

  • 2周至17岁因急性呼吸衰竭接受机械通气的患儿,来自RESTORE试验。
  • 评估时间点为基线、出院时、儿科ICU出院后6个月功能状态,以及出院后6个月HRQL。

诊断标准与关键阈值

  • 基线功能正常者,若婴儿与幼儿生活质量问卷-97生长与发育评分或儿科生活质量量表总分低于常模均值超过1个标准差,则判定为HRQL受损。

研究设计与关键结果

  • 研究类型为基于RESTORE试验的分析,样本量949例,人群为2周至17岁机械通气急性呼吸衰竭患儿。
  • 949例中192例从基线至出院后功能衰退;271例中55例(20%)生长与发育受损;343例中64例(19%)HRQL受损。
  • 多变量分析中功能衰退与基线功能受损、早产、癌症、呼吸衰竭病因、通气时长及可乐定相关(OR=2.14,95%CI 1.22-3.76)。
  • 生长与发育受损的独立预测因素包括美沙酮(OR=2.27,95%CI 1.18-4.36)和疼痛管理不足(OR=2.94,95%CI 1.39-6.19)。
  • HRQL受损与年龄较大、非白人/西班牙裔、癌症及镇静管理不足相关(OR=3.15,95%CI 1.74-5.72)。

证据类型、等级与局限

  • 证据类型为基于RESTORE随机对照试验的队列分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为儿童呼吸衰竭后出院后发病率常见,与入院因素、重症治疗暴露及疼痛和镇静管理相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Rationale: Poor outcomes of adults surviving critical illness are well documented, but data in children are limited.Objectives: To identify factors associated with worse postdischarge function and health-related quality of life (HRQL) after pediatric acute respiratory failure.Methods: We assessed functional status at baseline, discharge, and 6 months after pediatric ICU discharge and HRQL 6 months after discharge in 2-week- to 17-year-olds mechanically ventilated for acute respiratory failure in the RESTORE (Randomized Evaluation of Sedation Titration for Respiratory Failure) trial. We assessed HRQL via Infant and Toddler Quality of Life Questionnaire-97 (<2 yr old) or Pediatric Quality of Life Inventory (≥2 yr old). We categorized patients with normal baseline function as having impaired HRQL if scores were greater than 1 SD below mean norms for Infant and Toddler Quality of Life Questionnaire-97 growth and development or Pediatric Quality of Life Inventory total score.Measurements and Main Results: One-fifth (n = 192) of 949 patients declined in function from baseline to postdischarge; 20% (55/271) had impaired growth and development; 19% (64/343) had impaired HRQL. In multivariable analyses, decline in function was associated with baseline impaired function, prematurity, cancer, respiratory failure etiology, ventilation duration, and clonidine (odds ratio [OR] = 2.14; 95% confidence interval [CI] = 1.22-3.76). Independent predictors of impaired growth and development included methadone (OR = 2.27; 95% CI = 1.18-4.36) and inadequate pain management (OR = 2.94; 95% CI = 1.39-6.19). Impaired HRQL was associated with older age, non-white or Hispanic race, cancer, and inadequate sedation management (OR = 3.15; 95% CI = 1.74-5.72).Conclusions: Postdischarge morbidity after respiratory failure is common and associated with admission factors, exposure to critical care therapies, and pain and sedation management.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Watson RS, Asaro LA, Hutchins L, et al. Risk Factors for Functional Decline and Impaired Quality of Life after Pediatric Respiratory Failure. Am J Respir Crit Care Med. 2019. PMID: 31034245. doi:10.1164/rccm.201810-1881OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。